Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smad3
|
ENSMUSG00000032402.6 | Smad3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Smad3 | chr9_63749069_63749635 | 1725 | 0.420107 | 0.34 | 8.9e-03 | Click! |
Smad3 | chr9_63702561_63702866 | 9256 | 0.230457 | 0.32 | 1.2e-02 | Click! |
Smad3 | chr9_63749643_63749797 | 1357 | 0.496946 | 0.29 | 2.3e-02 | Click! |
Smad3 | chr9_63716045_63716691 | 4399 | 0.268128 | 0.29 | 2.3e-02 | Click! |
Smad3 | chr9_63759849_63760000 | 1930 | 0.382137 | -0.26 | 4.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_101884566_101885570 | 3.44 |
Lmo7 |
LIM domain only 7 |
949 |
0.69 |
chr11_100144835_100146198 | 3.37 |
Krt19 |
keratin 19 |
604 |
0.52 |
chr2_180332745_180333375 | 3.30 |
Gata5os |
GATA binding protein 5, opposite strand |
203 |
0.89 |
chr18_61663030_61663726 | 3.29 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
2112 |
0.18 |
chr15_25942218_25942426 | 3.21 |
Retreg1 |
reticulophagy regulator 1 |
357 |
0.88 |
chr4_141421681_141422558 | 3.09 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
1340 |
0.25 |
chr8_57319308_57320679 | 2.99 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr6_34599135_34600037 | 2.72 |
Cald1 |
caldesmon 1 |
966 |
0.58 |
chr1_45311634_45311944 | 2.67 |
Gm47302 |
predicted gene, 47302 |
116 |
0.54 |
chr11_72408624_72409355 | 2.64 |
Smtnl2 |
smoothelin-like 2 |
2722 |
0.18 |
chr2_148441004_148443557 | 2.60 |
Cd93 |
CD93 antigen |
1283 |
0.41 |
chr9_56866808_56868850 | 2.51 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
2796 |
0.18 |
chr13_113662906_113663717 | 2.47 |
Hspb3 |
heat shock protein 3 |
365 |
0.85 |
chr2_76805862_76806506 | 2.40 |
Ttn |
titin |
20358 |
0.22 |
chr16_72807953_72808738 | 2.35 |
Robo1 |
roundabout guidance receptor 1 |
145141 |
0.05 |
chr18_61663767_61665554 | 2.26 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
830 |
0.45 |
chr11_85833878_85836704 | 2.21 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr12_40471563_40472715 | 2.17 |
Dock4 |
dedicator of cytokinesis 4 |
25803 |
0.2 |
chr14_26441705_26442045 | 2.16 |
Slmap |
sarcolemma associated protein |
780 |
0.6 |
chr5_102724663_102726037 | 2.12 |
Arhgap24 |
Rho GTPase activating protein 24 |
377 |
0.93 |
chr3_79885722_79887545 | 2.10 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr6_113471485_113472483 | 2.09 |
Il17rc |
interleukin 17 receptor C |
299 |
0.76 |
chr2_155611238_155612364 | 2.04 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
589 |
0.53 |
chr18_4351025_4351657 | 2.04 |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
1616 |
0.24 |
chr3_79783789_79784614 | 2.01 |
Rxfp1 |
relaxin/insulin-like family peptide receptor 1 |
46321 |
0.11 |
chr11_96928897_96930218 | 2.01 |
Prr15l |
proline rich 15-like |
163 |
0.89 |
chr11_34845636_34846358 | 1.99 |
Gm22022 |
predicted gene, 22022 |
3643 |
0.22 |
chr1_73961876_73963067 | 1.99 |
Tns1 |
tensin 1 |
572 |
0.8 |
chr11_106712849_106713135 | 1.97 |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
1954 |
0.26 |
chr17_44189530_44190092 | 1.97 |
Clic5 |
chloride intracellular channel 5 |
1227 |
0.59 |
chr15_85297584_85298676 | 1.95 |
Fbln1 |
fibulin 1 |
34676 |
0.14 |
chr6_141252051_141252954 | 1.93 |
Gm28523 |
predicted gene 28523 |
2493 |
0.28 |
chr13_50958059_50958704 | 1.92 |
Gm19009 |
predicted gene, 19009 |
98225 |
0.07 |
chr19_36118883_36119585 | 1.91 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
676 |
0.71 |
chr7_142576289_142578620 | 1.91 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chrX_159942973_159943935 | 1.89 |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
436 |
0.87 |
chr19_8990872_8991023 | 1.88 |
Ahnak |
AHNAK nucleoprotein (desmoyokin) |
1652 |
0.21 |
chr16_38363311_38363597 | 1.88 |
Popdc2 |
popeye domain containing 2 |
1209 |
0.35 |
chr1_45314284_45314516 | 1.87 |
Gm47302 |
predicted gene, 47302 |
2727 |
0.27 |
chr2_91035627_91036540 | 1.86 |
Rapsn |
receptor-associated protein of the synapse |
442 |
0.7 |
chr7_141079729_141081054 | 1.85 |
Pkp3 |
plakophilin 3 |
611 |
0.5 |
chr3_20153383_20154068 | 1.85 |
Gyg |
glycogenin |
1344 |
0.46 |
chr5_65080055_65080510 | 1.83 |
Tmem156 |
transmembrane protein 156 |
11302 |
0.17 |
chr5_113136296_113136937 | 1.80 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
1370 |
0.27 |
chr12_9570099_9571217 | 1.80 |
1700022H16Rik |
RIKEN cDNA 1700022H16 gene |
73 |
0.9 |
chr11_96251471_96253106 | 1.78 |
Gm53 |
predicted gene 53 |
244 |
0.82 |
chr3_102087585_102087846 | 1.78 |
Casq2 |
calsequestrin 2 |
1076 |
0.43 |
chr18_61651079_61652393 | 1.76 |
Mir143 |
microRNA 143 |
2478 |
0.16 |
chr12_74340523_74341167 | 1.76 |
Gm9544 |
predicted gene 9544 |
5496 |
0.18 |
chr1_61402413_61403049 | 1.75 |
9530026F06Rik |
RIKEN cDNA 9530026F06 gene |
24299 |
0.16 |
chr6_52290702_52291897 | 1.74 |
Gm44294 |
predicted gene, 44294 |
5825 |
0.08 |
chr14_27237814_27239092 | 1.74 |
Gm49616 |
predicted gene, 49616 |
391 |
0.49 |
chr11_76435834_76437863 | 1.72 |
Abr |
active BCR-related gene |
372 |
0.87 |
chr9_105520039_105521535 | 1.71 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr1_118481967_118482873 | 1.70 |
Clasp1 |
CLIP associating protein 1 |
381 |
0.8 |
chr10_127514499_127515877 | 1.69 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
221 |
0.87 |
chr19_46623097_46624579 | 1.67 |
Wbp1l |
WW domain binding protein 1 like |
437 |
0.77 |
chr1_69787280_69787681 | 1.66 |
Gm37930 |
predicted gene, 37930 |
16612 |
0.22 |
chr11_22799849_22800588 | 1.65 |
Gm12058 |
predicted gene 12058 |
12971 |
0.13 |
chr7_143106768_143108439 | 1.65 |
Kcnq1 |
potassium voltage-gated channel, subfamily Q, member 1 |
52 |
0.95 |
chr12_112491805_112491979 | 1.65 |
A530016L24Rik |
RIKEN cDNA A530016L24 gene |
2418 |
0.24 |
chr4_120161120_120162185 | 1.65 |
Edn2 |
endothelin 2 |
446 |
0.87 |
chr11_104578496_104579513 | 1.64 |
Myl4 |
myosin, light polypeptide 4 |
1321 |
0.29 |
chr12_85451749_85452557 | 1.64 |
Gm40477 |
predicted gene, 40477 |
15904 |
0.14 |
chr4_156058523_156059788 | 1.63 |
Ttll10 |
tubulin tyrosine ligase-like family, member 10 |
189 |
0.76 |
chr3_53630832_53631463 | 1.62 |
Frem2 |
Fras1 related extracellular matrix protein 2 |
21083 |
0.16 |
chr11_37117318_37117871 | 1.62 |
Tenm2 |
teneurin transmembrane protein 2 |
118288 |
0.07 |
chr2_91118182_91118787 | 1.61 |
Mybpc3 |
myosin binding protein C, cardiac |
340 |
0.81 |
chr18_69925227_69926323 | 1.61 |
Ccdc68 |
coiled-coil domain containing 68 |
199 |
0.94 |
chr3_133233594_133234317 | 1.61 |
Arhgef38 |
Rho guanine nucleotide exchange factor (GEF) 38 |
934 |
0.64 |
chr2_167690537_167691384 | 1.60 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
217 |
0.84 |
chr7_81057643_81058977 | 1.60 |
Alpk3 |
alpha-kinase 3 |
710 |
0.41 |
chr19_34253411_34255499 | 1.60 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr3_104790520_104791322 | 1.60 |
Rhoc |
ras homolog family member C |
1062 |
0.32 |
chr18_4352221_4352475 | 1.59 |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
609 |
0.49 |
chr6_50807935_50808256 | 1.59 |
Gm44109 |
predicted gene, 44109 |
5064 |
0.18 |
chr1_40465628_40466339 | 1.58 |
Il18r1 |
interleukin 18 receptor 1 |
13 |
0.98 |
chr5_151126014_151126578 | 1.58 |
Stard13 |
StAR-related lipid transfer (START) domain containing 13 |
1247 |
0.57 |
chr4_137471203_137471685 | 1.57 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
2641 |
0.2 |
chr5_119832754_119833593 | 1.56 |
Tbx5 |
T-box 5 |
505 |
0.67 |
chr15_89020379_89020612 | 1.54 |
Mov10l1 |
Mov10 like RISC complex RNA helicase 1 |
74 |
0.93 |
chr5_77113895_77114483 | 1.53 |
Hopx |
HOP homeobox |
932 |
0.47 |
chr9_44070512_44070914 | 1.53 |
Gm39325 |
predicted gene, 39325 |
755 |
0.35 |
chrX_142684757_142686445 | 1.52 |
Tmem164 |
transmembrane protein 164 |
2713 |
0.28 |
chr11_8662599_8662811 | 1.52 |
Tns3 |
tensin 3 |
1830 |
0.5 |
chr6_145796214_145796726 | 1.52 |
Rassf8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
11913 |
0.2 |
chr7_142473834_142474084 | 1.52 |
Lsp1 |
lymphocyte specific 1 |
1035 |
0.36 |
chr7_142654280_142656231 | 1.51 |
Mir483 |
microRNA 483 |
259 |
0.76 |
chr3_19264771_19265033 | 1.51 |
Pde7a |
phosphodiesterase 7A |
63 |
0.98 |
chr6_56901300_56901698 | 1.51 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
384 |
0.8 |
chr9_24773249_24774873 | 1.50 |
Tbx20 |
T-box 20 |
223 |
0.92 |
chr3_129330284_129331144 | 1.50 |
Enpep |
glutamyl aminopeptidase |
1550 |
0.35 |
chr4_137470074_137470685 | 1.48 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
1576 |
0.29 |
chr13_34725859_34726844 | 1.48 |
Gm47151 |
predicted gene, 47151 |
5600 |
0.13 |
chr8_36952884_36953385 | 1.48 |
Dlc1 |
deleted in liver cancer 1 |
9 |
0.98 |
chr6_4488753_4490330 | 1.47 |
Gm37883 |
predicted gene, 37883 |
5343 |
0.17 |
chr19_47228729_47229498 | 1.47 |
Neurl1a |
neuralized E3 ubiquitin protein ligase 1A |
202 |
0.9 |
chr9_58309544_58310675 | 1.47 |
Loxl1 |
lysyl oxidase-like 1 |
3077 |
0.21 |
chrX_7657114_7658745 | 1.47 |
Prickle3 |
prickle planar cell polarity protein 3 |
457 |
0.47 |
chr1_134802830_134803774 | 1.46 |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
549 |
0.61 |
chr6_97929540_97930859 | 1.46 |
Mitf |
melanogenesis associated transcription factor |
400 |
0.89 |
chr12_54201730_54202443 | 1.46 |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
1774 |
0.33 |
chr15_66891047_66892576 | 1.45 |
Ccn4 |
cellular communication network factor 4 |
303 |
0.9 |
chr18_35739288_35740804 | 1.44 |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
30 |
0.95 |
chr5_119830922_119832010 | 1.44 |
Gm43050 |
predicted gene 43050 |
325 |
0.82 |
chr10_76724744_76726005 | 1.44 |
Col6a1 |
collagen, type VI, alpha 1 |
794 |
0.59 |
chr12_100779025_100779814 | 1.43 |
Dglucy |
D-glutamate cyclase |
283 |
0.88 |
chr11_94392276_94393158 | 1.42 |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
203 |
0.93 |
chr13_92793484_92793635 | 1.42 |
Thbs4 |
thrombospondin 4 |
1259 |
0.51 |
chr11_75165245_75169157 | 1.42 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr8_119670488_119671282 | 1.41 |
Gm32352 |
predicted gene, 32352 |
4 |
0.96 |
chr5_76876047_76876300 | 1.41 |
Aasdh |
aminoadipate-semialdehyde dehydrogenase |
494 |
0.77 |
chr5_122093323_122094551 | 1.41 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
7014 |
0.14 |
chr2_132944858_132946039 | 1.41 |
Fermt1 |
fermitin family member 1 |
181 |
0.93 |
chr16_14706735_14707615 | 1.39 |
Snai2 |
snail family zinc finger 2 |
1323 |
0.53 |
chr19_36734732_36735279 | 1.38 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
1648 |
0.41 |
chr6_48739497_48740057 | 1.38 |
Gimap1 |
GTPase, IMAP family member 1 |
670 |
0.27 |
chr15_93824709_93825690 | 1.38 |
Gm49445 |
predicted gene, 49445 |
161 |
0.97 |
chr3_97337256_97337873 | 1.38 |
Bcl9 |
B cell CLL/lymphoma 9 |
39647 |
0.14 |
chr11_102989753_102990660 | 1.38 |
Dcakd |
dephospho-CoA kinase domain containing |
7342 |
0.12 |
chr9_85324630_85325846 | 1.37 |
Tent5a |
terminal nucleotidyltransferase 5A |
1886 |
0.28 |
chr15_89425017_89425997 | 1.35 |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
288 |
0.74 |
chr14_34375555_34377243 | 1.35 |
Mmrn2 |
multimerin 2 |
678 |
0.52 |
chr17_75180042_75180607 | 1.35 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
1413 |
0.5 |
chr17_72921491_72924008 | 1.35 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr13_63250847_63251888 | 1.33 |
Gm47603 |
predicted gene, 47603 |
4197 |
0.11 |
chr2_114051146_114052179 | 1.33 |
Actc1 |
actin, alpha, cardiac muscle 1 |
1225 |
0.4 |
chr10_63457257_63458786 | 1.33 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr3_129215238_129216443 | 1.33 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
1565 |
0.34 |
chr2_148437602_148438018 | 1.32 |
Cd93 |
CD93 antigen |
5753 |
0.17 |
chr11_111583176_111584131 | 1.32 |
Gm11676 |
predicted gene 11676 |
29653 |
0.25 |
chr9_95256675_95257394 | 1.31 |
Slc9a9 |
solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
135348 |
0.04 |
chr10_79776981_79777609 | 1.31 |
Fstl3 |
follistatin-like 3 |
3 |
0.93 |
chr6_91214341_91214693 | 1.31 |
Fbln2 |
fibulin 2 |
1686 |
0.29 |
chr8_70493071_70496051 | 1.31 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr8_123157519_123158497 | 1.30 |
Sult5a1 |
sulfotransferase family 5A, member 1 |
220 |
0.84 |
chr8_61902204_61902661 | 1.30 |
Palld |
palladin, cytoskeletal associated protein |
237 |
0.92 |
chr5_75734553_75735176 | 1.30 |
Gm43101 |
predicted gene 43101 |
34 |
0.97 |
chr6_124925245_124926316 | 1.29 |
Mlf2 |
myeloid leukemia factor 2 |
5606 |
0.08 |
chr11_26489894_26490276 | 1.29 |
Fancl |
Fanconi anemia, complementation group L |
21750 |
0.21 |
chr8_57326741_57329467 | 1.28 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr6_17308527_17309109 | 1.28 |
Cav1 |
caveolin 1, caveolae protein |
1095 |
0.51 |
chr5_139351436_139351943 | 1.27 |
Cox19 |
cytochrome c oxidase assembly protein 19 |
271 |
0.78 |
chr8_107545084_107547731 | 1.26 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr6_115989023_115989958 | 1.25 |
Plxnd1 |
plexin D1 |
5515 |
0.17 |
chr10_81196473_81196648 | 1.25 |
Atcayos |
ataxia, cerebellar, Cayman type, opposite strand |
1869 |
0.13 |
chr18_11047852_11049020 | 1.25 |
Gata6os |
GATA binding protein 6, opposite strand |
799 |
0.66 |
chr13_116186833_116187552 | 1.25 |
Rpl34-ps2 |
ribosomal protein L34, pseudogene 2 |
33411 |
0.21 |
chr11_78982711_78982932 | 1.25 |
Lgals9 |
lectin, galactose binding, soluble 9 |
2010 |
0.31 |
chr12_90737821_90739146 | 1.24 |
Dio2 |
deiodinase, iodothyronine, type II |
45 |
0.78 |
chr10_45048086_45048775 | 1.24 |
Prep |
prolyl endopeptidase |
18773 |
0.15 |
chr6_52211753_52213405 | 1.24 |
Hoxa3 |
homeobox A3 |
536 |
0.36 |
chr15_25941347_25942080 | 1.24 |
Retreg1 |
reticulophagy regulator 1 |
826 |
0.63 |
chr18_12504148_12505078 | 1.24 |
Gm29200 |
predicted gene 29200 |
187 |
0.73 |
chr3_30104992_30105810 | 1.23 |
Mecom |
MDS1 and EVI1 complex locus |
35022 |
0.17 |
chr14_101884207_101884496 | 1.23 |
Lmo7 |
LIM domain only 7 |
232 |
0.96 |
chr13_73970701_73971191 | 1.22 |
Zdhhc11 |
zinc finger, DHHC domain containing 11 |
7084 |
0.1 |
chr8_77681755_77682458 | 1.22 |
Gm45714 |
predicted gene 45714 |
22415 |
0.14 |
chr12_73587091_73587345 | 1.21 |
Prkch |
protein kinase C, eta |
2375 |
0.29 |
chr3_98280396_98280830 | 1.21 |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
178 |
0.93 |
chr6_3399116_3399544 | 1.21 |
Samd9l |
sterile alpha motif domain containing 9-like |
242 |
0.92 |
chr14_69994534_69995596 | 1.20 |
Gm33524 |
predicted gene, 33524 |
62302 |
0.09 |
chr10_24595254_24596595 | 1.19 |
Gm15270 |
predicted gene 15270 |
107 |
0.55 |
chr17_43389439_43390317 | 1.19 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
390 |
0.89 |
chr2_74678970_74680401 | 1.19 |
Hoxd11 |
homeobox D11 |
128 |
0.86 |
chr5_119838900_119840891 | 1.18 |
Tbx5 |
T-box 5 |
3740 |
0.21 |
chr1_43159364_43159948 | 1.18 |
Fhl2 |
four and a half LIM domains 2 |
4305 |
0.2 |
chr11_18873955_18876215 | 1.18 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
776 |
0.61 |
chr8_109185308_109186079 | 1.18 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
64173 |
0.13 |
chr2_114047360_114047667 | 1.18 |
Actc1 |
actin, alpha, cardiac muscle 1 |
5374 |
0.17 |
chr14_54988853_54989389 | 1.17 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1703 |
0.14 |
chr6_85371815_85372854 | 1.17 |
Rab11fip5 |
RAB11 family interacting protein 5 (class I) |
2230 |
0.24 |
chr5_119799485_119800879 | 1.17 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
7485 |
0.19 |
chr1_131232374_131233673 | 1.17 |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
552 |
0.67 |
chr18_13786670_13786902 | 1.17 |
Zfp521 |
zinc finger protein 521 |
57046 |
0.16 |
chr17_70755180_70756155 | 1.17 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
85 |
0.97 |
chr16_9016414_9016572 | 1.17 |
Gm49447 |
predicted gene, 49447 |
20097 |
0.16 |
chr15_84719703_84721036 | 1.16 |
Gm20556 |
predicted gene, 20556 |
103 |
0.74 |
chr14_65360226_65361166 | 1.16 |
Gm48449 |
predicted gene, 48449 |
1286 |
0.37 |
chr4_118488388_118488809 | 1.16 |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
1157 |
0.32 |
chr19_20600997_20601809 | 1.16 |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
558 |
0.79 |
chr5_119669544_119672401 | 1.16 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr2_90964960_90965890 | 1.16 |
Celf1 |
CUGBP, Elav-like family member 1 |
333 |
0.83 |
chr1_171437287_171438855 | 1.16 |
F11r |
F11 receptor |
492 |
0.63 |
chr7_29290890_29291737 | 1.16 |
Ppp1r14a |
protein phosphatase 1, regulatory inhibitor subunit 14A |
2001 |
0.19 |
chr5_125003119_125004344 | 1.15 |
Rflna |
refilin A |
256 |
0.92 |
chr4_29133351_29134210 | 1.15 |
Gm11918 |
predicted gene 11918 |
7834 |
0.23 |
chrX_20869884_20870823 | 1.15 |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
132 |
0.93 |
chr6_124717857_124719000 | 1.15 |
Mir200c |
microRNA 200c |
38 |
0.7 |
chr8_106604509_106604660 | 1.15 |
Cdh1 |
cadherin 1 |
441 |
0.81 |
chr14_63244119_63245953 | 1.15 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr11_58998976_58999701 | 1.15 |
Obscn |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
1021 |
0.3 |
chr7_142662290_142664788 | 1.15 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr11_63131178_63131912 | 1.15 |
Pmp22 |
peripheral myelin protein 22 |
33 |
0.98 |
chrX_114477896_114478376 | 1.14 |
Klhl4 |
kelch-like 4 |
3532 |
0.28 |
chr17_17827521_17828536 | 1.14 |
Spaca6 |
sperm acrosome associated 6 |
704 |
0.43 |
chr1_78817332_78818790 | 1.14 |
Kcne4 |
potassium voltage-gated channel, Isk-related subfamily, gene 4 |
1134 |
0.48 |
chr4_130310070_130310553 | 1.13 |
Gm10570 |
predicted gene 10570 |
1637 |
0.25 |
chr7_130948781_130949200 | 1.13 |
Htra1 |
HtrA serine peptidase 1 |
5501 |
0.2 |
chr4_19724825_19725683 | 1.13 |
Gm12354 |
predicted gene 12354 |
5055 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.6 | GO:0003166 | bundle of His development(GO:0003166) |
1.0 | 5.2 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.9 | 2.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.8 | 4.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 2.3 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.7 | 2.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 2.7 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.7 | 2.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.7 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.7 | 2.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.7 | 2.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 2.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 2.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 1.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 1.6 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 1.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.5 | 1.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 1.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.5 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 1.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 1.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 0.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 1.3 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 0.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 1.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.6 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.4 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 2.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 0.8 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.4 | 1.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 1.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.4 | 1.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 1.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 1.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.3 | 2.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 0.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.3 | 3.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 1.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 1.0 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 0.3 | GO:0070305 | response to cGMP(GO:0070305) |
0.3 | 1.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 1.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 1.2 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.3 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 0.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 0.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.9 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 1.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 0.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.3 | 0.8 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 0.6 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 1.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 2.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 1.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 0.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 0.8 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.3 | 0.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 1.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 0.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 2.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 1.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 0.5 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.3 | 1.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 0.8 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.3 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 1.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 0.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 1.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 1.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 1.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.2 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.2 | 0.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.9 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.2 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.2 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.9 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.2 | 2.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.7 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.5 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 1.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.9 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 0.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.4 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.2 | 2.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.2 | 1.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 2.5 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 1.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 2.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.8 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.2 | 0.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 2.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.4 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.6 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.2 | 1.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.4 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.2 | 0.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 0.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.4 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.2 | 0.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.2 | 0.6 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.6 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.6 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 3.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 0.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.2 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.2 | 1.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.4 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 0.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 3.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 2.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 1.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.2 | GO:0060526 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.2 | 0.5 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 1.8 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 0.5 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.2 | 0.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.3 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.2 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 0.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 1.3 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.2 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.6 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.6 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 1.0 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.4 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.0 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.7 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 2.5 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 1.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.5 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.8 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 1.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 1.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 1.9 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.5 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 1.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 1.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.5 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 1.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 1.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 3.1 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 1.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.8 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.4 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.3 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 1.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.3 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 2.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.8 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.1 | 1.9 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0061184 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) positive regulation of dermatome development(GO:0061184) |
0.1 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.1 | 0.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.2 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.2 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
0.1 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.1 | 2.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:2000343 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 1.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.1 | 0.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.1 | 5.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 1.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.1 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 1.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 1.7 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 1.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.3 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.1 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.1 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.8 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 1.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 1.1 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.2 | GO:0090504 | epiboly(GO:0090504) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.0 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.0 | 0.6 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0072683 | T cell extravasation(GO:0072683) |
0.0 | 0.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.4 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.1 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.0 | 0.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.3 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.3 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.0 | 0.0 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.0 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.0 | 0.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.0 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.4 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.0 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.0 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.0 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.0 | 0.5 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.4 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.0 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.0 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.0 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0044321 | response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.1 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.0 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.3 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.2 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.0 | GO:0048880 | sensory system development(GO:0048880) |
0.0 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.1 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.0 | GO:0061440 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.1 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.0 | 0.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 0.1 | GO:0002715 | regulation of natural killer cell mediated immunity(GO:0002715) |
0.0 | 0.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.0 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.0 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.0 | 0.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 2.7 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 1.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.6 | 2.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 2.1 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 2.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 1.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 2.9 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 2.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 0.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 3.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 2.0 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.7 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 0.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 1.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 2.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.2 | 2.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 5.7 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 1.4 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 1.9 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.3 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 2.9 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 7.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 2.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 2.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.5 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 9.2 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 3.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.5 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 4.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.2 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 4.9 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 13.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 2.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 11.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.7 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 3.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 2.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 6.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 1.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.0 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 2.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 1.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.5 | 5.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 1.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 1.3 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 2.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 2.1 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 2.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 3.1 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 3.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 4.8 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 1.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 2.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.4 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 2.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 2.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 3.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 3.5 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 1.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 9.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 4.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 2.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 2.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 2.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.8 | GO:0043759 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 6.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.7 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 1.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.6 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 2.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.8 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 1.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 4.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 2.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 1.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 1.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.4 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 9.9 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0018650 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 1.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.4 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.0 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 9.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 8.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 1.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 5.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 6.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 4.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 3.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 2.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 4.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 3.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 4.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 11.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 6.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 2.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 2.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 6.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 8.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 14.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 2.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 4.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 4.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.0 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 2.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |